Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Molecular Cancer Therapeutics
|
August 7, 2023
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource
Joel Morris, Mark W Kunkel, Stephen L White, et al.
Cancer Research
|
October 26, 2018
The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel
Anne Monks, Yingdong Zhao, Curtis Hose, et al.
JCO Precision Oncology
|
August 25, 2020
Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African Ancestry
Marco Matejcic, Yesha Patel, Jenna Lilyquist, et al.
JAMA Oncology
|
February 17, 2022
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis
Kathryn P Lowry, H Amarens Geuzinge, Natasha K Stout, et al.
Journal of the National Cancer Institute
|
August 13, 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
Hermela Shimelis, Holly LaDuca, Chunling Hu, et al.
American Journal of Human Genetics
|
February 28, 2024
Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain
Chunling Hu, Huaizhi Huang, Jie Na, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer
Siddhartha Yadav, Chunling Hu, Steven N Hart, et al.
The Journal of Molecular Diagnostics : JMD
|
February 12, 2017
Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial
Chih-Jian Lih, Robin D Harrington, David J Sims, et al.
Journal of the National Cancer Institute
|
May 20, 2020
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women
Julie R Palmer, Eric C Polley, Chunling Hu, et al.
NPJ Breast Cancer
|
July 13, 2024
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
Peter A Fasching, Chunling Hu, Steven N Hart, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Molecular Cancer Therapeutics
|
August 7, 2023
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource
Joel Morris, Mark W Kunkel, Stephen L White, et al.
Cancer Research
|
October 26, 2018
The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel
Anne Monks, Yingdong Zhao, Curtis Hose, et al.
JCO Precision Oncology
|
August 25, 2020
Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African Ancestry
Marco Matejcic, Yesha Patel, Jenna Lilyquist, et al.
JAMA Oncology
|
February 17, 2022
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis
Kathryn P Lowry, H Amarens Geuzinge, Natasha K Stout, et al.
Journal of the National Cancer Institute
|
August 13, 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
Hermela Shimelis, Holly LaDuca, Chunling Hu, et al.
American Journal of Human Genetics
|
February 28, 2024
Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain
Chunling Hu, Huaizhi Huang, Jie Na, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer
Siddhartha Yadav, Chunling Hu, Steven N Hart, et al.
The Journal of Molecular Diagnostics : JMD
|
February 12, 2017
Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial
Chih-Jian Lih, Robin D Harrington, David J Sims, et al.
Journal of the National Cancer Institute
|
May 20, 2020
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women
Julie R Palmer, Eric C Polley, Chunling Hu, et al.
NPJ Breast Cancer
|
July 13, 2024
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
Peter A Fasching, Chunling Hu, Steven N Hart, et al.
Page
of 12